Akero Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
52.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.74
|
-0.92
|
-0.18
|
-24.32%
|
|
2022-06-30
|
-0.86
|
-0.77
|
0.09
|
10.47%
|
|
2022-03-31
|
-0.80
|
-0.74
|
0.06
|
7.50%
|
|
2021-12-31
|
-0.82
|
-0.93
|
-0.11
|
-13.41%
|
|
2021-09-30
|
-0.91
|
-0.70
|
0.21
|
23.08%
|
|
2021-06-30
|
-0.72
|
-0.83
|
-0.11
|
-15.28%
|
|
2021-03-31
|
-0.91
|
-0.43
|
0.48
|
52.75%
|
|
2020-12-31
|
-0.59
|
-0.86
|
-0.27
|
-45.76%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.43
|
|
2021-12-31
|
-2.89
|
|
2020-12-31
|
-2.48
|
|
2019-12-31
|
-3.55
|
|
2018-12-31
|
-0.76
|